Literature DB >> 2104852

Three-dimensional structure of human erythrocytic purine nucleoside phosphorylase at 3.2 A resolution.

S E Ealick1, S A Rule, D C Carter, T J Greenhough, Y S Babu, W J Cook, J Habash, J R Helliwell, J D Stoeckler, R E Parks.   

Abstract

The three-dimensional structure of human erythrocytic purine nucleoside phosphorylase has been determined at 3.2 A resolution using x-ray diffraction data. Intensity data were measured using radiation from the Synchrotron Radiation Source, Daresbury, England, and oscillation film techniques. Phases were determined by using multiple isomorphous replacement methods with four heavy-atom derivatives and were improved using solvent flattening techniques. Purine nucleoside phosphorylase exists in the crystal as a trimer in which subunits are related by a crystallographic 3-fold axis. Each subunit contains an eight-stranded mixed beta-sheet and a five-stranded mixed beta-sheet which join to form a distorted beta-barrel structure. This core beta-structure is flanked by seven alpha-helices in a manner that generates a novel folding pattern. The active site, which was characterized from binding of the substrate analogs 8-iodoguanine and 5'-iodoformycin B, is located near the subunit-subunit boundary within the trimer and involves seven different segments from one subunit and an additional short segment from an adjacent subunit. In the crystal, the phosphate-binding site is probably occupied by a sulfate ion. The specificity of purine nucleoside phosphorylase for guanine, hypoxanthine, and their analogs can be explained on the basis of the arrangement of hydrogen bond donors and acceptors in the active site.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104852     DOI: 10.2210/pdb2pnp/pdb

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors.

Authors:  S E Ealick; Y S Babu; C E Bugg; M D Erion; W C Guida; J A Montgomery; J A Secrist
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

2.  Preliminary crystallographic studies of purine nucleoside phosphorylase from the cariogenic pathogen Streptococcus mutans.

Authors:  Qiao Ming Hou; Xiang Liu; Erik Brostromer; Lan Fen Li; Xiao Dong Su
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-11-27

Review 3.  Symmetry, stability, and dynamics of multidomain and multicomponent protein systems.

Authors:  T L Blundell; N Srinivasan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Point mutations at the purine nucleoside phosphorylase locus impair thymocyte differentiation in the mouse.

Authors:  F F Snyder; J P Jenuth; E R Mably; R K Mangat
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

5.  Glycal formation in crystals of uridine phosphorylase.

Authors:  Debamita Paul; Seán E O'Leary; Kanagalaghatta Rajashankar; Weiming Bu; Angela Toms; Ethan C Settembre; Jennie M Sanders; Tadhg P Begley; Steven E Ealick
Journal:  Biochemistry       Date:  2010-04-27       Impact factor: 3.162

6.  Inhibition and structure of Toxoplasma gondii purine nucleoside phosphorylase.

Authors:  Teraya M Donaldson; María B Cassera; Meng-Chiao Ho; Chenyang Zhan; Emilio F Merino; Gary B Evans; Peter C Tyler; Steven C Almo; Vern L Schramm; Kami Kim
Journal:  Eukaryot Cell       Date:  2014-02-28

7.  L-Enantiomers of transition state analogue inhibitors bound to human purine nucleoside phosphorylase.

Authors:  Agnes Rinaldo-Matthis; Andrew S Murkin; Udupi A Ramagopal; Keith Clinch; Simon P H Mee; Gary B Evans; Peter C Tyler; Richard H Furneaux; Steven C Almo; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2007-12-23       Impact factor: 15.419

8.  Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency.

Authors:  M R Aust; L G Andrews; M J Barrett; C J Norby-Slycord; M L Markert
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

9.  Cloning, purification and characterisation of a recombinant purine nucleoside phosphorylase from Bacillus halodurans Alk36.

Authors:  Daniel F Visser; Fritha Hennessy; Konanani Rashamuse; Maureen E Louw; Dean Brady
Journal:  Extremophiles       Date:  2010-03       Impact factor: 2.395

10.  Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT.

Authors:  Sepideh Afshar; Tove Olafsen; Anna M Wu; Sherie L Morrison
Journal:  J Exp Clin Cancer Res       Date:  2009-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.